Key result
Angiotensin II reduces uveoscleral outflow by ~19% via AT1 rather than AT2 receptors.
Why the study?
The physiological role of ocular angiotensin II in regulating uveoscleral outflow was unclear due to previously observed small effects of AT1 receptor antagonists.
Does ocular angiotensin II influence uveoscleral outflow regulation in rabbits?
Does ocular angiotensin II influence uveoscleral outflow regulation in rabbits?
Ocular angiotensin II attenuates uveoscleral outflow via AT1 receptors in rabbits, though its physiological effect is not critical in intraocular pressure regulation.
Answers are grounded in this paper and cite their sources.
Rabbit eye data do not warrant IOP therapy changes; hypothesis-generating for AT1 effects on uveoscleral outflow, needs in vivo validation.
PURPOSE: In our previous study, we showed that the AT1 receptor antagonist increased uveoscleral outflow (USF) when topically applied to the rabbit eye. However this increase was too small to demonstrate a clear physiological role for ocular angiotensin II (AII). Hence, the purpose of this study was to determine whether ocular AII influenced USF regulation, and if so, how this occurred. METHODS: USF was measured by the FITC-dextran perfusion method in albino rabbits. AII and its receptor antagonists were directly applied into the anterior chamber by adding into the perfusate and by perfusing with FITC-dextran. We also analyzed angiotensin receptors on the rabbit ciliary body membrane by a receptor binding assay with 125I-[Sar1), Ile8]-AII as a ligand. RESULTS: CS-088 (1 microg/ml) increased USF by 24% while AII decreased USF in a concentration-dependent manner between 10 and 500 nM. Its maximum decrease of 19% occurred at 500 nM. At this AII concentration the USF reduction was antagonized by 1 microg/ml CS-088, an AT1-receptor antagonist, but not by the same concentration of PD-123,177, an AT2-receptor antagonist. Specific 125I-[Sar1, Ile8]-AII binding to the rabbit ciliary body membranes was inhibited by CS-088 with an inhibition constant of 7.05 nM, whereas inhibition by PD-123,177 was not observed. CONCLUSIONS: Ocular AII was indicated to attenuate USF via AT1 receptors in rabbits, however its physiological effect was not critical in IOP regulation.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2001) studied this question. Angiotensin II (AII) and receptor antagonists (CS-088, PD-123,177) was evaluated on Uveoscleral outflow (USF). Angiotensin II decreased uveoscleral outflow by up to 19% at 500 nM, an effect antagonized by the AT1-receptor antagonist CS-088 but not the AT2-receptor antagonist PD-123,177.
Synapse has enriched 10 related papers. Consider them for comparative context: